As ‘cultural weight’ of a psychedelic approval looms, FDA hearing focuses on access and safety

As the FDA marches toward the likely first approval of a psychedelic medicine, the agency today convened a hearing seeking public input on how these drugs should be used, monitored and continuously studied in the real world.